Department of Otolaryngology, Mayo Clinic, Rochester, Minnesota, USA.
Ear Hear. 2010 Apr;31(2):186-94. doi: 10.1097/AUD.0b013e3181c6b831.
The primary objective of this study was to determine whether a revision and/or expansion of current audiologic cochlear implant candidacy criteria is warranted.
The study design was a retrospective review of postoperative speech perception performance for 22 adult cochlear implant recipients who demonstrated preoperative Consonant Nucleus Consonant word recognition scores of 30% or higher in the best-aided condition. This criterion was chosen to exceed that specified by the North American clinical trial of the Nucleus Freedom cochlear implant system.
The mean preoperative best-aided monosyllabic word score for the 22 patients was 41% correct. The degree of postoperative benefit for the best postoperative condition (electric only or bimodal) ranged from 10 to 68 percentage points with a mean benefit of 27 percentage points for the electric-only condition and 40 percentage points for the bimodal condition. Statistical analyses revealed highly significant differences between preoperative-aided, implant-only, and bimodal performance on Consonant Nucleus Consonant monosyllabic word recognition performance. That is, both postoperative scores--electric only and bimodal--were significantly different from one another and from the preoperative best-aided performance.
The current results suggest that a large-scale reassessment of manufacturer and Medicare preoperative audiologic candidacy criteria for adults is warranted to allow more hearing-impaired individuals to take advantage of the benefits offered by cochlear implantation.
本研究的主要目的是确定是否需要对当前的听力学人工耳蜗植入候选标准进行修订和/或扩展。
研究设计为对 22 名成年人工耳蜗植入接受者的术后言语感知表现进行回顾性研究,这些接受者在最佳辅助条件下的术前辅音核辅音词识别测试中得分达到 30%或以上。选择这一标准是为了超过北美 Nucleus Freedom 人工耳蜗系统临床试验规定的标准。
22 名患者的术前最佳辅助单音节词平均得分正确的为 41%。最佳术后条件(仅电刺激或双模式)的术后获益程度范围为 10%至 68%,电刺激条件的平均获益为 27%,双模式条件的平均获益为 40%。统计分析显示,术前辅助、植入物和双模式在辅音核辅音单音节词识别性能方面存在显著差异。也就是说,术后的两种评分(仅电刺激和双模式)彼此之间以及与术前最佳辅助表现均存在显著差异。
目前的结果表明,有必要对制造商和医疗保险的成人术前听力学候选标准进行大规模重新评估,以使更多听力受损的人能够受益于人工耳蜗植入带来的好处。